BioCardia, Inc.Giá lên
BCDA Setting up for a Long?
I'm adding a new stock to my watchlist. BCDA has Market Cap of 36.28 M and an Enterprise Value of 31.32 M. It has 31.3% insider ownership with the management buying shares each month since September 2022 through December 2022. They create cellular therapeutics for cardiovascular diseases. Their revenue has been growing 11% per year over the past 5 years. Price project is now set to $6.22 (344%) move in the future.
I see many are trapped in the $3.69 area.
Do your own due diligence not stock advice. Just my thoughts.
BCDA has Market Cap of 36.28 M and an Enterprise Value of 31.32 M. It has 31.3% insider ownership with the management buying shares each month since September 2022 through December 2022. They create cellular therapeutics for cardiovascular diseases. Their revenue has been growing 11% per year over the past 5 years. Price project is now set to $6.22 (344%) move in the future.I see many are trapped in the $3.69 area.
Do your own due diligence not stock advice. Just my thoughts.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.